FDC Limited (NSE:FDC)
401.90
+0.05 (0.01%)
Apr 2, 2025, 3:29 PM IST
FDC Limited Revenue
FDC Limited had revenue of 4.64B INR in the quarter ending December 31, 2024, with 1.30% growth. This brings the company's revenue in the last twelve months to 20.78B, up 8.49% year-over-year. In the fiscal year ending March 31, 2024, FDC Limited had annual revenue of 19.43B with 8.92% growth.
Revenue (ttm)
20.78B
Revenue Growth
+8.49%
P/S Ratio
n/a
Revenue / Employee
3.12M
Employees
6,659
Market Cap
65.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 19.43B | 1.59B | 8.92% |
Mar 31, 2023 | 17.84B | 2.56B | 16.74% |
Mar 31, 2022 | 15.28B | 1.95B | 14.61% |
Mar 31, 2021 | 13.33B | -109.88M | -0.82% |
Mar 31, 2020 | 13.44B | 2.53B | 23.24% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
FDC Limited News
- 3 months ago - FDC receives US FDA approval for Cefixime 400 mg tablets - Business Upturn
- 7 months ago - FDC shares surge 11%, leading gains in BSE Healthcare index - Business Upturn